EWING, N.J., Nov. 18, 2016 /PRNewswire/ -- Essential Pharmaceuticals, LLC Chief Science Officer, Dr. Adam Elhofy, has published new data on Cell-Ess® universal titer boost and optimizer in BioProcess International. The article, titled "Providing Lipids Boosts Protein Productivity: Testing a Feed Supplement with Multiple Cell Clones and Media
Photo - http://photos.prnewswire.com/prnh/20161117/441002 Logo - http://photos.prnewswire.com/prnh/20161117/441001LOGO
Cell-Ess is a universal titer boost and optimizer that can be added to an already optimized media to increase total yield and productivity per cell without impacting metabolic profile, glycosylation pattern or downstream processing. In a 5-minute video, Dr. Elhofy and Essential Pharmaceuticals CEO Allan Weber discuss what makes Cell-Ess so unique and how it's revolutionizing media optimization.
"The data published in BioProcess International demonstrate that Cell-Ess consistently increases protein productivity regardless of the media and feed scheme utilized," says Dr. Elhofy. "In addition, the study was performed with different CHO clones and at different locations, demonstrating the robustness of Cell-Ess as a titer boost in many different systems."
"At Essential Pharmaceuticals, we pride ourselves in providing solutions to meet bioproduction needs," says Allan Weber, CEO of Essential. "Process development scientists and manufacturers are able to improve their processes by simply adding Cell-Ess to their current system. The new data published in BioProcess International Magazine highlights the flexibility of Cell-Ess and provides guidance to scientists as they continue improving their processes."
About Essential Pharmaceuticals
Essential Pharmaceuticals provides surgeons, medical researchers, and manufacturers new tools to bring performance, convenience, and control to enhance the advancement of basic research and drug discovery. Established in 2006, Essential Pharmaceuticals supports the preservation and growth of human systems through expanding its product development to further medical treatments for mankind.
For more information, visit www.EssentialPharma.com or contact Denise Weber at the corporate office: 1-844-Ess-Prod; Email: [email protected]
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/new-bioproduction-data-on-cell-ess-universal-titer-boost-is-published-by-essential-pharmaceuticals-300365730.html
SOURCE Essential Pharmaceuticals, LLC
Subscribe to our Free Newsletters!
Routes of drug administration play a major role in a medical treatment. Selecting a right route of ...
Spinal anesthesia and epidural anesthesia are types of regional anesthesia in which when a drug is ...
Colorectal cancer is a cancer that starts in the colon or the rectum. Colo-rectal cancer is the ...View All